Dear Sir, We report here an instance of drug-related thrombocytopenia associated to infliximab and later on with adalimumab in a patient with Crohn disease (CD). A 42-year-old woman was diagnosed of colonic CD with perianal fistulae lesions (PDAI = 11). She was treated with metronidazole and azathioprine. After two months, the patient remained symptomatic and three infusions with infliximab (monoclonal antibody against tumor necrosis factor α (TNF-α)) at a dose of 5mg/kg were administered at 0, 2 and 6 weeks. Symptoms decreased and improvement was noted (PDAI = 2).
- crohn disease
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.